# Diafert for Embryo Selection and Fertility Improvement (DESTINy)

> **NCT02593513** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 108 (actual)

## Conditions studied

- Infertility

## Interventions

- **DEVICE:** Daifert
- **PROCEDURE:** Control Group

## Key facts

- **NCT ID:** NCT02593513
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-26
- **Primary completion:** 2017-02-22
- **Final completion:** 2017-04-07
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593513, "Diafert for Embryo Selection and Fertility Improvement (DESTINy)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02593513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*